Cargando…
Effect of intravenous almitrine on intubation or mortality in patients with COVID-19 acute hypoxemic respiratory failure: A multicentre, randomised, double-blind, placebo-controlled trial
BACKGROUND: Severe hypoxemia in patients with COVID-19 pneumonia might result from hypoxic pulmonary vasoconstriction, contributing to ventilation/perfusion (V/Q) mismatch. Because almitrine improves V/Q, it might reduce the risk for mechanical ventilation (MV) in such patients. Our primary objectiv...
Autores principales: | Kalfon, Pierre, Payen, Jean-François, Rousseau, Alexandra, Chousterman, Benjamin, Cachanado, Marine, Tibi, Annick, Audibert, Juliette, Depret, François, Constantin, Jean-Michel, Weiss, Emmanuel, Remerand, Francis, Freund, Yonathan, Simon, Tabassome, Riou, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489996/ https://www.ncbi.nlm.nih.gov/pubmed/36157895 http://dx.doi.org/10.1016/j.eclinm.2022.101663 |
Ejemplares similares
-
Treating hypoxemic COVID-19 “ARDS” patients with almitrine: The earlier the better?
por: Bendjelid, Karim, et al.
Publicado: (2020) -
Rescue therapy with inhaled nitric oxide and almitrine in COVID-19 patients with severe acute respiratory distress syndrome
por: Bagate, François, et al.
Publicado: (2020) -
Early and comprehensive care bundle in the elderly for acute heart failure in the emergency department: study protocol of the ELISABETH stepped-wedge cluster randomized trial
por: Freund, Yonathan, et al.
Publicado: (2019) -
Efficacy of Almitrine in the Treatment of Hypoxemia in Sars-Cov-2 Acute Respiratory Distress Syndrome
por: Barthélémy, Romain, et al.
Publicado: (2020) -
Almitrine as a non-ventilatory strategy to improve intrapulmonary shunt in COVID-19 patients
por: Losser, Marie-Reine, et al.
Publicado: (2020)